Literature DB >> 27271285

Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.

Konstantin Holzapfel1, Jochen Gaa2, Elaine C Schubert2, Matthias Eiber3, Joerg Kleeff4, Ernst J Rummeny2, Martin Loos4.   

Abstract

PURPOSE: To evaluate diffusion-weighted MR imaging (DWI) in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.
METHODS: In 24 patients with cholangiocarcinoma, MR imaging of the upper abdomen was performed prior to surgery at 1.5 T using a respiratory-triggered single-shot echo-planar imaging (SSEPI) sequence (b values: 50, 300, and 600 s/mm(2)). ADC (apparent diffusion coefficient) values and diameters of regional lymph nodes (LN) were determined. Subsequently, in all patients, surgical exploration and/or resection of the primary tumor and regional LN dissection were performed. Imaging results were correlated with results of histopathologic analysis. ADC values and diameters of benign and malignant LN were compared using the Mann-Whitney U test. In addition, a ROC (receiver operating characteristic curve) analysis was performed.
RESULTS: The mean ADC value (×10(-3) mm(2)/s) of metastatic LN (1.21 ± 0.15) was significantly lower than that of benign LN (1.62 ± 0.33, p < 0.001) while there was no significant difference in the mean diameter of malignant (16.8 ± 5.4 mm) and benign LN (14.1 ± 4.0 mm; p = 0.09). Using an ADC value of 1.25 × 10(-3) mm(2)/s as threshold, 91.4% of LN were correctly classified as benign or malignant with a sensitivity/specificity of 83.3%/92.8% and a positive/negative predictive value of 66.7%/96.7%. The area under the ROC curve was 0.93.
CONCLUSION: DWI using a respiratory-triggered SSEPI sequence, according to our preliminary experience, is a promising imaging modality in the differentiation of benign and malignant LN in patients with cholangiocarcinoma.

Entities:  

Keywords:  Cholangiocarcinoma; Diffusion-weighted MR imaging (DWI); Lymph node metastases; MR imaging

Mesh:

Year:  2016        PMID: 27271285     DOI: 10.1007/s00261-016-0791-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  10 in total

1.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

2.  Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-04-19       Impact factor: 3.452

3.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

4.  With 3 Types of Respiratory Acquisition: 3.0 T Respiratory Triggered Acquisition Can Obtain Higher Quality DWI Images of the Upper Abdomen.

Authors:  Zhuo Shi; Jiuming Jiang; Han Ouyang; Lizhi Xie; Xinming Zhao
Journal:  Contrast Media Mol Imaging       Date:  2022-07-09       Impact factor: 3.009

5.  The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer.

Authors:  Jinrong Qu; Chen Shen; Jianjun Qin; Zhaoqi Wang; Zhenyu Liu; Jia Guo; Hongkai Zhang; Pengrui Gao; Tianxia Bei; Yingshu Wang; Hui Liu; Ihab R Kamel; Jie Tian; Hailiang Li
Journal:  Eur Radiol       Date:  2018-07-23       Impact factor: 5.315

6.  Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Wenhua Liu; Junlin He; Zongqiong Sun; Yuxi Ge; Weiqiang Dou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-12       Impact factor: 5.555

Review 7.  Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.

Authors:  Michał Frączek; Hubert Kamecki; Anna Kamecka; Roman Sosnowski; Katarzyna Sklinda; Marcin Czarniecki; Leszek Królicki; Jerzy Walecki
Journal:  Transl Androl Urol       Date:  2018-10

8.  Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.

Authors:  Yong Tang; Chun Mei Yang; Song Su; Wei Jia Wang; Li Ping Fan; Jian Shu
Journal:  BMC Cancer       Date:  2021-11-24       Impact factor: 4.430

9.  Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma.

Authors:  Yan-Jie Shi; Bo-Nan Liu; Xiao-Ting Li; Hai-Tao Zhu; Yi-Yuan Wei; Bo Zhao; Shao-Shuai Sun; Ying-Shi Sun; Chun-Yi Hao
Journal:  Abdom Radiol (NY)       Date:  2021-11-20

10.  Associations Between Apparent Diffusion Coefficient Value With Pathological Type, Histologic Grade, and Presence of Lymph Node Metastases of Esophageal Carcinoma.

Authors:  Yating Wang; Genji Bai; Lili Guo; Wei Chen
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.